Provided by Tiger Trade Technology Pte. Ltd.

Merck

119.63
+0.70000.59%
Post-market: 119.27-0.3600-0.30%19:59 EDT
Volume:8.35M
Turnover:1.00B
Market Cap:296.92B
PE:16.43
High:121.07
Open:119.29
Low:118.60
Close:118.93
52wk High:125.14
52wk Low:73.31
Shares:2.48B
Float Shares:2.48B
Volume Ratio:0.60
T/O Rate:0.34%
Dividend:3.24
Dividend Rate:2.71%
EPS(TTM):7.28
EPS(LYR):7.28
ROE:36.88%
ROA:12.04%
PB:5.64
PE(LYR):16.43

Loading ...

Dow Jones Top Company Headlines at 7 AM ET: Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns | Sony, ...

Dow Jones
·
Mar 25

Merck to Acquire Terns Pharmaceuticals for $6.7 Billion Equity Value

MT Newswires Live
·
Mar 25

Merck braces for Keytruda patent loss with $6.7 billion Terns bet

Reuters
·
Mar 25

Merck to acquire Terns Pharmaceuticals for $53.00 per share in cash, or $6.7B

TIPRANKS
·
Mar 25

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

GlobeNewswire
·
Mar 25

Merck & Co Inc - Deal Value About $5.7 Bln Net of Cash, 31% Premium to 60-Day Vwap as of March 24, 2026

THOMSON REUTERS
·
Mar 25

Merck & Co Inc - Deal Expected to Close in Q2 2026 With $5.8 Bln or About $2.35 per Share Charge in Q2 and FY2026 Results

THOMSON REUTERS
·
Mar 25

Merck & Co Inc - Deal Approved by Both Boards; Closing Subject to Majority of Terns Stockholders Tendering Shares

THOMSON REUTERS
·
Mar 25

Deals of the day-Mergers and acquisitions

Reuters
·
Mar 25

Terns Pharmaceuticals Shares up 14.1% Premarket After FT Reports Merck Nears $6 Bln Acquisition of Co

THOMSON REUTERS
·
Mar 25

Merck Nears Acquisition of Terns Pharmaceuticals to Strengthen Blood Cancer Treatment Portfolio

Stock News
·
Mar 25

Merck nears $6 billion all-cash deal to buy Terns Pharma, FT reports

Reuters
·
Mar 25

BRIEF-Merck Nears $6Bn Biotech Deal To Boost Cancer Drug Pipeline - Ft

Reuters
·
Mar 25

Talks Between Merck and Terns Were at an Advanced Stage and Deal Could Be Reached in Coming Days - FT

THOMSON REUTERS
·
Mar 25

Merck's All-Cash Deal Is Expected to Value Terns at Roughly $6Bn - FT

THOMSON REUTERS
·
Mar 25

Merck Nears $6Bn Biotech Deal to Boost Cancer Drug Pipeline - FT

THOMSON REUTERS
·
Mar 25

Quotient Therapeutics Announces Collaboration With Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology

THOMSON REUTERS
·
Mar 24

Is Long-Term GARDASIL Protection Data Reframing The Vaccine Investment Case For Merck (MRK)?

Simply Wall St.
·
Mar 24

Merck & Co. Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 24

Merck’s Emerging HIV Franchise: Undervalued Long-Acting Opportunity in a $25B+ Market Supporting a Buy Rating

TIPRANKS
·
Mar 23